Proceedings: Arterial thromboembolism and prosthetic heart valves. Effects of acetylsalicylic acid. 1975

J Dale, and E Myhre, and O Storstein, and H Stormorken

UI MeSH Term Description Entries
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin

Related Publications

J Dale, and E Myhre, and O Storstein, and H Stormorken
January 1987, Advances in experimental medicine and biology,
J Dale, and E Myhre, and O Storstein, and H Stormorken
December 1992, Hospital practice (Office ed.),
J Dale, and E Myhre, and O Storstein, and H Stormorken
August 1969, The Annals of thoracic surgery,
J Dale, and E Myhre, and O Storstein, and H Stormorken
January 1988, Seminars in thrombosis and hemostasis,
J Dale, and E Myhre, and O Storstein, and H Stormorken
December 1982, Modern concepts of cardiovascular disease,
J Dale, and E Myhre, and O Storstein, and H Stormorken
August 1994, Cardiology clinics,
J Dale, and E Myhre, and O Storstein, and H Stormorken
April 1967, Circulation,
J Dale, and E Myhre, and O Storstein, and H Stormorken
March 1978, The American journal of cardiology,
J Dale, and E Myhre, and O Storstein, and H Stormorken
November 1975, New York state journal of medicine,
J Dale, and E Myhre, and O Storstein, and H Stormorken
June 2002, Cleveland Clinic journal of medicine,
Copied contents to your clipboard!